Skip to content

Home Map The News Technology Politics Business Sports Entertainment Science Health World

Global AI-Powered News Intelligence. Real-time headlines, mapped by continent and country, from news sources worldwide.

Powered by AI

Navigate

Home
Map The News
About
Sources & methodology
Sources & methodology
Search

Sections

Technology
Politics
Business
Sports
Entertainment
Science

More

Privacy
Contact
Sitemap
Robots

© 2026 newsGlobal. All rights reserved.

Headlines refresh every 10 minutes.

Home Map Search Topics About

Health

AstraZeneca advances weight-loss pill to take aim at obesity leaders

Financial Times

HealthFinancial Times·Jun 8, 2026·1 min read

AstraZeneca advances weight-loss pill to take aim at obesity leaders

Pill from drugmaker would put it into competition with market leaders Novo Nordisk and Eli Lilly

View original source — Financial Times ↗

ShareShare on X Share on Facebook

Related stories

The Wegovy pill is still dominating the GLP-1 pill market

WorldJun 7, 2026 · 1 min

The Wegovy pill is still dominating the GLP-1 pill market

WorldJun 8, 2026 · 1 min

Novo and Lilly are competing to win the GLP-1 pill market as they prepare for Medicare coverage

GLP-1 Craze Fuels Protein-Powder Maker Glanbia’s Share Rally

WorldJun 17, 2026 · 1 min

GLP-1 Craze Fuels Protein-Powder Maker Glanbia’s Share Rally

WorldJun 19, 2026 · 1 min

Zealand Pharma stock suffered its two worst days on record. Here's what's next for the weight loss drugmaker